CClinicalTrials.gg
CompletedNCT03039270Updated Feb 1, 2017

Evaluation of Sensitivity With and Without Sonic Activation of a Desensitizing Gel Before in Office Bleaching in Adults

An interventional study of With sonic activation (SMART Device®) and Control (Without sonic activation) in Dentin Sensitivity and Tooth Bleaching, sponsored by Federal University of Amazonas. Completed at 1 site in Brazil. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2017-02-01.

Sponsored by Federal University of Amazonas · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 1 year after the study started (first participant enrolled Jan 2016, registered Jan 2017).
Phase
Not applicable
Study type
Interventional
Enrollment
31
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This randomized, controlled clinical trial, triple-blind, split-mouth type was conducted aiming to assess the absolute risk of sensitivity with and without sonic activation of a desensitizing gel previously to the in-office bleaching in adults.

Read the detailed description

This clinical trial evaluated the effect of sonic activation of a desensitizing gel on the occurrence of sensitivity associated with office bleaching. For this, 31 patients had their anterior superior teeth divided into right and left, according to the sonic activation (AS) or not (SS) of the desensitizer. Prior to bleaching, a desensitizing gel containing 5% potassium nitrate and 2% sodium fluoride (Desensibilize KF2%, FGM Dental Products,SC, Brazil) was applied. Sonic activation was performed with a sonic device (Smart, FGM Dental Products, SC, Brazil) at the 170 MHz frequency. A hydrogen peroxide gel (Whiteness HP Maxx, FGM Dental Products, SC, Brazil) was used in two whitening sessions. It was also performed, evaluation of the presence of cracks in enamel, through transillumination. The color change was verified using two color scales and a spectrophotometer. The dental sensitivity was recorded through a sensitivity diary answered by the patient, in the period up to 48 hours after each bleaching session. The absolute risk of tooth sensitivity was compared using the McNemar test (= 5%). The color change was analyzed from the variation of units of scale vita (SGU) and through the value of ΔE, which were compared through Student t test (α = 5%).

02

Conditions studied

  • Dentin Sensitivity
  • Tooth Bleaching

Keywords

  • Tooth Sensitivity
  • Tooth Bleaching
  • Desensitizing agent
  • Sonic vibration
03

In context

Dentin Sensitivity

283 studies on the registry are indexed under Dentin Sensitivity; 45 are open to participants now.

This study's enrollment of 31 is below the median of 60 across 274 interventional studies indexed under Dentin Sensitivity.

Browse Dentin Sensitivity studies →

Lead sponsor

Federal University of Amazonas is the lead sponsor of 2 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Patients had at least six upper anterior teeth free of caries and restorations on the vestibular surface, and at least one central or canine incisor showing A2 or darker coloration, evaluated in comparison with a visual scale of color orientated by the value of the teeth (Vita Classical, Vita-Zahnfabrik- Germany).

Exclusion criteria

Exclusion Criteria:

  • Users of fixed orthodontic appliances, pregnant or lactating, with the presence of severe intrinsic stains on the teeth (spots on the use of tetracycline, fluorosis and depolluted teeth), who were taking any medication with action Anti-inflammatory and antioxidant, using desensitizing dentifrice and participants with previous history of dental sensitivity or any associated pathology (bruxism, gingival recession, non-carious lesion with dentin exposure).
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
31 participants (actual)

Study arms

  • Active comparator
    Control (Without sonic activation)

    Desensitizing gel applied without sonic activation, for 10 minutes, previously to the in-office bleaching.

    Other: Control (Without sonic activation)

  • Experimental
    With sonic activation (SMART Device®)

    Desensitizing gel applied with sonic activation, 30 seconds per tooth, previously to the in-office bleaching.

    Other: With sonic activation (SMART Device®)

Interventions

  • OtherWith sonic activation (SMART Device®)

    The operator applied a desensitizing gel containing 5% potassium nitrate and 2% sodium fluoride (Desensibilize KF 2%, FGM, SC, Brazil) on the vestibular surfaces of the participant's anterior teeth. In the sonic activation side, immediately after the gel's application, sonic activation(Smart Sonic Device, FGM, SC, Brazil) was performed for 1.5 minutes in total for side (30 seconds per tooth). After the time of 30 seconds in each of the three anterior teeth of the respective side, the gel was removed from teeth with cotton. After removal of the desensitizing gel, gingival tissues were isolated and the bleaching gel were applied.

    Also known as: Sonic vibration

  • OtherControl (Without sonic activation)

    The operator applied a desensitizing gel containing 5% potassium nitrate and 2% sodium fluoride (Desensibilize KF 2%, FGM,SC, Brazil) on the vestibular surfaces of the participant's anterior teeth. In the side allocated for application without sonic activation, gel was kept for 10 minutes, after which it was removed from the teeth. After removal of the desensitizing gel, gingival tissues were isolated and the bleaching gel were applied.

06

What researchers measure

Primary outcomes

  1. Absolute risk of tooth sensitivity

    Number of patients experiencing sensitivity at least once during the two whitening sessions.

    Time frame: Throughout two bleaching sessions, in the period immediately after bleaching up to 48 hours.

Secondary outcomes

  1. Bleaching effectiveness

    Change of color of teeth after bleaching.

    Time frame: Measured by the difference between the baseline color and 30 days after the second bleaching session.

  2. Intensity of pain experienced, as measured by two pain scales.

    Intensity of pain experienced

    Time frame: Throughout two bleaching sessions, in the period immediately after bleaching up to 48 hours.

07

Study locations

1 site
  • Faculty of Dentistry, Federal University of Amazonas
    Manaus, Amazonas 69025-050, Brazil
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 1, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03039270
Lead sponsor
Federal University of Amazonas
Collaborators
Coordination for the Improvement of Higher Education Personnel
Responsible party
Verônica Pereira de Lima Bertocco (Graduate student, Federal University of Amazonas) — Principal investigator
First posted
Feb 1, 2017
Start date
Jan 18, 2016
Primary completion
Mar 31, 2016
Completion
Apr 15, 2016
Last update
Feb 1, 2017

Study contacts

Verônica Bertocco
principal investigator · Federal University of Amazonas

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion